Effect of epidermal growth factor and prostaglandin on the expression of aromatase (CYP19) in human adrenocortical carcinoma cell line NCI-H295R cells

Journal of Endocrinology

Volumn 188, Issue 1, 2006, Pages 59-68

  Watanabe, Masatada ^a   Noda, Mariko ^a   Nakajin, Shizuo ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; EPIDERMAL GROWTH FACTOR; PROSTAGLANDIN; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; PROSTAGLANDIN RECEPTOR EP1; PROSTAGLANDIN RECEPTOR EP2; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG;

ADRENAL CORTEX CARCINOMA; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; ENZYME ACTIVITY; EXON; GENE ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROSTAGLANDIN RELEASE; PROTEIN EXPRESSION; UPREGULATION;

ADRENAL CORTEX NEOPLASMS; ALPROSTADIL; AROMATASE; BENZYLAMINES; CELL LINE, TUMOR; DINOPROST; DINOPROSTONE; EPIDERMAL GROWTH FACTOR; EXONS; FLAVONOIDS; HUMANS; ISOQUINOLINES; PROMOTER REGIONS (GENETICS); PROSTAGLANDINS; PROSTAGLANDINS A; PROSTAGLANDINS E; PROTEIN KINASE INHIBITORS; RECEPTORS, PROSTAGLANDIN E; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STIMULATION, CHEMICAL; SULFONAMIDES;

EID: 31544480894     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.06214     Document Type: Article

References (21)

1. Bulun SE, Takayama K, Suzuki T, Sasano H, Yilmaz B & Sebastian S 2004 Organization of the human aromatase p450 (CYP19) gene. Seminars in Reproductive Medicine 22 5-9.
2. Doi J, Takemori H, Ohta M, Nonaka Y & Okamoto M 2001 Differential regulation of 3 beta-hydroxysteroid dehydrogenase type II and 17 alpha-hydroxylase/lyase P450 in human adrenocortical carcinoma cells by epidermal growth factor and basic fibroblast growth factor. Journal of Endocrinology 168 87-94.
3. Heneweer M, van den Berg M & Sanderson JT 2004 A comparison of human H295R and rat R2C cell lines as in vitro screening tools for effects on aromatase. Toxicology Letters 146 183-194.
4. 2 production by epidermal growth factor via mitogen-activated protein kinase in articular chondrocytes. Journal of Biological Chemistry 278 9691-9697.
5. 4 receptors in human monocytes stimulated with lipopolysaccharide from Actinobacillus actinomycetemcomitans and interferon-gamma. Oral Microbiology and Immunology 18 150-155.
6. Moroni M, Veronese S, Schiavo R, Carminati O, Sorensen BS, Gambacorta M & Siena S 2001 Epidermal growth factor receptor expression and activation in nonseminomatous germ cell tumors. Clinical Cancer Research 7 2770-2775.
7. Narumiya S & FitzGerald GA 2001 Genetic and pharmacological analysis of prostanoid receptor function. Journal of Clinical Investigation 108 25-30.
8. Nishi Y, Yanase T, Mu Y, Oba K, Ichino I, Saito M, Nomura M, Mukasa C, Okabe T, Goto K et al. 2001 Establishment and characterization of a steroidogenic human granulosa-like tumor cell line, KGN, that expresses functional follicle-stimulating hormone receptor. Endocrinology 142 437-445.
9. 2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nature Medicine 8 289-293.
10. Phornphutkul C, Okubo T, Wu K, Harel Z, Tracy TF Jr, Pinar H, Chen S, Gruppuso PA & Goodwin G 2001 Aromatase p450 expression in a feminizing adrenal adenoma presenting as isosexual precocious puberty. Journal of Clinical Endocrinology and Metabolism 86 649-652.
11. 2 regulates aromatase activity and expression in human adipose stromal cells via two distinct receptor subtypes. Journal of Clinical Endocrinology and Metabolism 88 2810-2816.
12. Richards JA, Petrel TA & Brueggemeier RW 2002 Signaling pathways regulating aromatase and cyclooxygenases in normal and malignant breast cells. Journal of Steroid Biochemistry and Molecular Biology 80 203-212.
13. Sasano H, Suzuki T, Shizawa S, Kato K & Nagura H 1994 Transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor expression in normal and diseased human adrenal cortex by immunohistochemistry and in situ hybridization. Modern Pathology 7 741-746.
14. 2 production by epidermal growth factor requires the coordinate activation of cytosolic phospholipase A2 and cyclooxygenase 2 in human squamous carcinoma A431 cells. Prostaglandins 53 355-369.
15. Schlotzer-Schrehardt U, Zenkel M & Nusing RM 2002 Expression and localization of FP and EP prostanoid receptor subtypes in human ocular tissues. Investigative Ophthalmology and Visual Science 43 1475-1487.
16. Shozu M, Sebastian S, Takayama K, Hsu WT, Schultz RA, Neely K, Bryant M & Bulun SE 2003 Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene. New England Journal of Medicine 348 1855-1865.
17. 4) in bone resorption: an analysis using specific agonists for the respective EPs. Endocrinology 141 1554-1559.
18. Watanabe M & Nakajin S 2004 Forskolin up-regulates aromatase (CYP19) activity and gene transcripts in the human adrenocortical carcinoma cell line H295R. Journal of Endocrinology 180 125-133.
19. Watanabe T, Yasuda T, Noda H, Wada K, Kazukawa I, Someya T, Minamitani K, Minagawa M, Wataki K, Matsunaga T et al. 2000 Estrogen secreting adrenal adenocarcinoma in an 18-month-old boy: aromatase activity, protein expression, mRNA and utilization of gonadal type promoter. Endocrine Journal 47 723-730.
20. Young J, Bulun SE, Agarwal V, Couzinet B, Mendelson CR, Simpson ER & Schaison G 1996 Aromatase expression in a feminizing adrenocortical tumor. Journal of Clinical Endocrinology and Metabolism 81 3173-3176.
21. 2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene. Endocrinology 137 5739-5742.